Free Trial

Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts

$13.04
-0.22 (-1.66%)
(As of 06/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 13)
-$5.98 Missed By -$4.80
Consensus EPS
(May. 13)
-$1.18
Skip Charts & View Estimated and Actual Earnings Data

AVTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avalo Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.91) EPS
Next Year EPS Consensus Estimate: ($0.97) EPS

AVTX Earnings Date and Information

Avalo Therapeutics last announced its earnings results on May 13th, 2024. The reported ($5.98) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.18) by $4.80. Avalo Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Avalo Therapeutics are expected to decrease in the coming year, from ($0.91) to ($0.97) per share. Avalo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Avalo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/13/2024Q1 2024($1.18)($5.98)($4.80)$129.04--
11/9/2023Q3 2023($264.00)($26.40)+$237.60($0.11)$1.00 million$0.24 million
8/3/2023Q2 2023($216.00)($141.60)+$74.40($0.59)$1.00 million$0.64 million
5/4/2023Q1 2023($232.80)($204.00)+$28.80($0.85)$1.00 million$0.48 million
3/29/2023Q4 2022($124.80)($249.60)($124.80)($1.04)$5.20 million$0.90 million
11/7/2022Q3 2022($247.20)$81.60+$328.80$0.34$1.40 million$14.95 million
8/4/2022Q2 2022($432.00)($331.20)+$100.80($1.38)-$1.03 million
5/5/2022Q1 2022($33.60)($48.00)($14.40)($0.20)-$1.17 million
3/2/2022Q4 2021($432.00)($460.80)($28.80)---
11/9/2021Q3 2021($518.40)($489.60)+$28.80($0.17)-$1.35 million
8/2/2021Q2 2021($518.40)($518.40)-($0.18)-$3.36 million
5/13/2021Q1 2021($662.40)($921.60)($259.20)($0.32)-$0.47 million
11/9/2020Q3 2020($288.00)($460.80)($172.80)($0.15)$1.50 million$1.11 million
8/6/2020Q2 2020($288.00)($432.00)($144.00)($0.11)$2.25 million$1.34 million
5/7/2020Q1 2020($345.60)($115.20)+$230.40$0.26$2.25 million$2.75 million
11/14/2019Q3 2019($489.60)($201.60)+$288.00($0.07)$5.15 million$5.61 million
8/8/2019Q2 2019($460.80)($374.40)+$86.40($0.15)$5.28 million$4.45 million

Avalo Therapeutics Earnings - Frequently Asked Questions

When is Avalo Therapeutics's earnings date?

Avalo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AVTX's earnings history.

Did Avalo Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($1.18) by $4.80 with a reported earnings per share (EPS) of ($5.98). Learn more on analysts' earnings estimate vs. AVTX's actual earnings.

How much revenue does Avalo Therapeutics generate each year?

Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $1.92 million.

How much profit does Avalo Therapeutics generate each year?

Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$31.54 million. AVTX has generated $0.00 earnings per share over the last four quarters.

What is Avalo Therapeutics's EPS forecast for next year?

Avalo Therapeutics's earnings are expected to decrease from ($0.91) per share to ($0.97) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AVTX) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners